Pharma Mar, S.A. (BME:PHM)
Spain
· Delayed Price · Currency is EUR 98.65
+1.80 (1.86%)
Apr 28, 2026, 5:35 PM CET
Pharma Mar Revenue
In the year 2025, Pharma Mar had annual revenue of 221.39M EUR with 26.61% growth. Pharma Mar had revenue of 90.48M in the quarter ending December 31, 2025, with 87.08% growth.
Revenue
221.39M
Revenue Growth
+26.61%
P/S Ratio
7.74
Revenue / Employee
438.40K
Employees
505
Market Cap
1.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 221.39M | 46.54M | 26.61% |
| Dec 31, 2024 | 174.86M | 16.70M | 10.56% |
| Dec 31, 2023 | 158.15M | -38.19M | -19.45% |
| Dec 31, 2022 | 196.34M | -33.49M | -14.57% |
| Dec 31, 2021 | 229.83M | -40.13M | -14.87% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Almirall | 1.11B |
| Faes Farma | 626.99M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 251.89M |
| Laboratorio Reig Jofre | 336.68M |
| Atrys Health | 144.31M |